What are the indications for N‑acetylcysteine (NAC) in acetaminophen (paracetamol) toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

NAC Indications in Paracetamol Toxicity

Administer N-acetylcysteine (NAC) to all patients with acute acetaminophen overdose whose serum levels fall above the Rumack-Matthew nomogram treatment line (possible or probable risk zones), ideally within 8-10 hours of ingestion to prevent severe hepatotoxicity and death. 1, 2

Primary Indication: Risk-Stratified Treatment

The core indication for NAC is determined by plotting the serum acetaminophen concentration on the Rumack-Matthew nomogram:

  • Measure serum acetaminophen level at 4 hours post-ingestion or later (never before 4 hours, as levels are unreliable) 2
  • Treat if level plots above the treatment line: This line starts at 150 mcg/mL at 4 hours and decreases to 50 mcg/mL at 12 hours 1, 2
  • The treatment line is set 25% below the original "probable toxicity" line to account for assay errors and provide a safety margin 1

Critical Timing Considerations

Time to treatment is the single most important prognostic factor:

  • <8 hours: No severe hepatotoxicity when NAC given 1
  • 8-10 hours: Minimal hepatotoxicity (one case of non-lethal injury in studies) 1
  • 10-16 hours: 29% developed severe hepatotoxicity 1
  • 16-24 hours: 62% developed severe hepatotoxicity 1
  • >24 hours: Still indicated, though less effective 2

When to Treat Empirically (Without Waiting for Levels)

Start NAC immediately in these situations:

  • Reported ingestion ≥150 mg/kg and level results will be delayed 2
  • Unknown time of ingestion with any detectable acetaminophen level
  • Suspected toxic ingestion when acetaminophen assay is unavailable 2
  • Chronic supratherapeutic ingestion with elevated transaminases

The FDA label explicitly states: "If an assay for acetaminophen cannot be obtained, it is necessary to assume that the overdose is potentially toxic." 2

When NOT to Treat

Do not administer NAC when the serum level plots below the treatment line on the nomogram (no risk zone), as this provides no benefit and exposes patients to unnecessary adverse effects 1. This applies only to acute single ingestions with reliable timing.

Special Populations Requiring Lower Treatment Threshold

Treat at 50% of the standard nomogram line (starting at 75 mcg/mL at 4 hours) in patients with:

  • Chronic alcohol use
  • Malnutrition
  • Enzyme-inducing medications (phenytoin, carbamazepine, rifampin)
  • Pre-existing liver disease

Mechanism and Efficacy

NAC works by replenishing hepatic glutathione stores, which normally detoxify the reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI) 3. When acetaminophen overwhelms normal metabolism, NAPQI accumulates and causes hepatocellular necrosis. NAC reduced mortality from 5% to 0% when given within 24 hours in landmark studies 1.

Common Pitfalls to Avoid

  • Never wait for levels if >8 hours post-ingestion: Start NAC empirically, then discontinue if level comes back non-toxic
  • Don't use the nomogram for chronic ingestions or extended-release formulations: These require clinical judgment based on levels and liver function
  • Don't stop NAC prematurely: Complete the full protocol unless clear stopping criteria are met (acetaminophen <10 mg/L, normal/improving transaminases, normal INR)
  • The nomogram only applies between 4-24 hours post-ingestion: Earlier or later levels require different interpretation

No Absolute Contraindications

There are no contraindications to NAC administration in acetaminophen toxicity 2. Anaphylactoid reactions occur in up to 10% of patients but are manageable and should not prevent treatment 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.